Skip to content
approvedHormone Regulation

Alarelin

Also known as: Alarelin Acetate, pGlu-His-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-NHEt, GnRH Agonist Alarelin, WAY-GnRH

Alarelin is a synthetic nonapeptide analog of gonadotropin-releasing hormone (GnRH) with a D-alanine substitution at position 6 and an ethylamide modification at the C-terminus. These modifications make it significantly more potent and longer-acting than native GnRH. It is primarily approved and used in veterinary medicine for reproductive management — inducing ovulation, synchronizing estrus, and treating reproductive disorders in livestock. In research, it serves as a tool for studying the hypothalamic-pituitary-gonadal axis.

3 cited references·5 researched benefits

Quick Answer

Alarelin is a synthetic GnRH (gonadotropin-releasing hormone) agonist nonapeptide with enhanced potency and stability compared to native GnRH. Approved for veterinary use, it induces ovulation and synchronizes estrus in livestock through the biphasic GnRH agonist mechanism — initial gonadotropin surge (flare) followed by pituitary desensitization and hormone suppression. In research, alarelin is used to study hypothalamic-pituitary-gonadal axis regulation and reproductive endocrinology.

Key Facts

Mechanism
Alarelin binds to GnRH receptors on pituitary gonadotroph cells with higher affinity and resistance to enzymatic degradation than native GnRH due to its D-Ala⁶ substitution and C-terminal ethylamide. Upon initial administration, it produces a "flare" effect — a supraphysiologic surge of LH and FSH release that can trigger ovulation. With continuous or repeated administration, alarelin causes GnRH receptor downregulation and desensitization, leading to suppression of gonadotropin secretion and subsequent reduction in sex steroid production (chemical castration effect). This biphasic response (initial stimulation followed by suppression) is characteristic of all GnRH agonists.
Research Status
approved
Half-Life
~3 hours (significantly longer than native GnRH at ~2–4 minutes)
Molecular Formula
C₅₆H₇₈N₁₆O₁₂
Primary Use
Hormone Regulation
Table of Contents

Benefits

  • Effective induction of ovulation in livestock reproductive management protocolsstrong
  • Synchronization of estrus cycles in cattle and other livestock for breeding programsstrong
  • Chemical suppression of sex steroids through GnRH receptor desensitization with prolonged usestrong
  • Valuable research tool for studying hypothalamic-pituitary-gonadal axis dynamicsmoderate
  • Potential application in reproductive medicine for controlled ovarian stimulation protocolspreliminary

Dosage Protocols

RouteDosage RangeFrequencyNotes
Intramuscular injection (veterinary)10–25 mcgSingle dose for ovulation inductionStandard veterinary protocol for inducing ovulation in cattle. Timing is synchronized with estrus detection or fixed-time AI protocols.
Subcutaneous injection (research)0.1–10 mcg/kgVariable depending on study protocolResearch dosing varies widely. Single doses study the flare effect; repeated doses study desensitization and gonadal suppression.

Medical disclaimer

Dosage information is provided for educational reference only. Always follow your prescriber's instructions and consult a qualified healthcare provider before starting any peptide protocol.

Side Effects

  • Initial gonadotropin flare — transient surge in LH, FSH, and sex steroids before suppressioncommon
  • Hot flashes and vasomotor symptoms during prolonged suppression phasecommon
  • Injection site reactions (redness, swelling)common
  • Bone density loss with prolonged continuous use due to hypogonadal stateserious
  • Mood changes and decreased libido during gonadotropin suppressioncommon

Frequently Asked Questions

Is alarelin used in humans?
Alarelin is primarily approved and used in veterinary medicine, particularly for reproductive management in livestock (cattle, pigs, fish). It is not widely used in human medicine, where other GnRH agonists like leuprolide (Lupron), goserelin (Zoladex), and triptorelin (Trelstar) are preferred. However, alarelin has been studied in human reproductive research and may have potential applications in assisted reproduction protocols. Its pharmacological mechanism is identical to human-approved GnRH agonists.
What is the GnRH agonist flare effect?
When a GnRH agonist like alarelin is first administered, it overstimulates GnRH receptors on pituitary gonadotroph cells, causing a massive release of LH and FSH — the "flare." This is why GnRH agonists can initially trigger ovulation or temporarily increase sex steroid levels. With continued administration, the constant receptor stimulation causes downregulation and desensitization, ultimately suppressing LH, FSH, and downstream sex hormones. This biphasic mechanism is exploited therapeutically: single doses for the flare (ovulation), continuous use for suppression.
How does alarelin compare to leuprolide and other GnRH agonists?
All GnRH agonists share the same biphasic mechanism (initial flare then suppression), but they differ in potency, half-life, and approved indications. Leuprolide (Lupron) is the most widely used human GnRH agonist, available in monthly and multi-month depot formulations for prostate cancer, endometriosis, and precocious puberty. Alarelin is primarily veterinary-focused. The D-amino acid substitution at position 6 and C-terminal modifications are common features across the class that enhance metabolic stability versus native GnRH.

References

  1. 1
    Alarelin — a potent GnRH agonist: effects on gonadotropin secretion and reproductive function(1988)PubMed ↗
  2. 2
    Application of GnRH agonists in animal reproduction: alarelin in ovulation synchronization protocols(1997)PubMed ↗
  3. 3
    GnRH and GnRH agonists: mechanisms of action and clinical applications in reproductive medicine(2003)PubMed ↗

Latest Research

Last updated: 2026-02-19